Safety/Efficacy Study of Subcutaneously Injected Prandial Insulins Compared to Insulin Lispro Alone in Participants With Type 1 Diabetes Mellitus

NCT01194245 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

135

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 1

Interventions

DRUG: Insulin lispro
DRUG: recombinant human hyaluronidase PH20
DRUG: Insulin aspart
DRUG: Insulin glulisine
DRUG: Insulin glargine

Sponsor

Halozyme Therapeutics